Teprotumumab Early Response Is Not Required for Benefit for Thyroid Eye Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Eye (London, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Teprotumumab for Thyroid Eye Disease: Early Response Is Not Required for Benefit
Eye (Lond) 2021 Jun 28;[EPub Ahead of Print], S Ugradar, Y Wang, T Mester, GJ Kahaly, RS DouglasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.